Gopal Nayak

The next Trivedi Online Workshop is scheduled at Noon, Pacific Time, August 31, 2019. To register, call 877-493-4092, or register via email at CS@TrivediEffect.com.

LAS VEGAS (PRWEB)
August 23, 2019

Authors Gopal Nayak and Mahendra Kumar Trivedi were recognized with International No. 1 best-selling status for the scientific research book “Impact of Biofield Treatment on Growth and Anatomical Characteristics of Pogostemon cablin (Benth.)” also known in the cosmetic and perfume industry as Patchouli.

The book garnered No. 1 status on Amazon in several categories including: Mind-Body Medicine, Herbal Remedies, Tropical Agriculture, Mind-Body Medicine, Aromatherapy, Medical Atlases, Nosology, Biophysics, Biochemistry, Sustainable Agriculture, Microbiology, Molecular Biology, Horticulture, Homeopathy, Pathophysiology, Biotechnology, and Holistic Medicine.

Gopal’s research focused on Pogostemoncablin, which is a known aromatic plant that is cultivated for its essential oil used widely in perfumery and cosmetic industries. In the present study, the effect of biofield treatment was studied on the growth of P. cablin. For this study an in-vitro culture system was set up in two groups, viz., control and treatment, each of which was derived from three different explant sources, namely leaf, node and petiole. Further these in-vitro plantlets were hardened and transferred to external environment. The stomatal cells and epidermal hair growth were also studied at various morphogenetic stages. The study revealed that a single transmission of a biofield energy treatment produced a significant increase in growth in the treated group throughout all the morphogenetic phases from in-vitro to in vivo level. A remarkable increase in stomatal cells and epidermal hair was also seen in the treated group.

Gopal Nayak is one of the youngest enlightened spiritual gurus for the new generation in India.

“Gopal is a pioneer in ushering in a new era of dogma-free spirituality to help people optimize their fate and fortune,” said Alice Branton, CEO of Trivedi Global, Inc.

Gopal has transformed the life thousands of individuals from around the world, especially in USA, Canada and Europe. People report an impact on problems related to physical, mental and emotional health, and improvement in business and finances as well as family and social relationships.

To find out more about the science, read testimonials, or join an upcoming workshop, visit http://www.TrivediEffect.com

About Guruji Mahendra Trivedi & The Trivedi Effect®

Guruji Mahendra Kumar Trivedi, the founder of the Trivedi Effect®, is on a mission to usher in a new era that integrates science, spirituality, and consciousness to vastly improve the human condition and benefit humanity on a global scale. To date, more than 250,000 people worldwide have benefited from the Trivedi Effect®. His organization, Trivedi Global, Inc., is collaborating with globally renowned product research and development organizations to bring to market proprietary products and therapies in the areas of nutraceuticals, pharmaceuticals, and more.

Alice Branton, CEO, Trivedi Global, Inc., recently spoke on the impact of the Trivedi Effect® at the Entrepreneurship Club of the Harvard Business School, Nasdaq, Microsoft, and Coca-Cola. She also appeared on more than 35 network television news shows in the last year including ABC, NBC, CBS, FOX, CW and more.

Dahryn Trivedi, a prodigious spiritual leader, young entrepreneur, inspiring Trivedi Effect speaker and paradigm-shifting scientist also joins in the mission. She recently spoke at NASDAQ and has been featured on ABC, NBC, and Fox.

The Trivedi Effect® has been tested, measured, and validated in over 4,000 scientific experiments globally, by world-renowned scientists and research institutes using the rigor of internationally accepted models of scientific research with the most sophisticated technologies available on this planet. Challenging the known frontiers of science, this research has resulted in over 350 publications in major international peer-reviewed scientific journals with over 4,000 citations. These publications are available in over 4,000 universities internationally including the prestigious Ivy League Universities, as well as, the National Institutes of Health (NIH).

The next Trivedi Online Workshop is scheduled at Noon, Pacific Time, August 31, 2019. To register, call 877-493-4092, or register via email at CS(at)TrivediEffect(dot)com.

Share article on social media or email:

Alice Branton, CEO of Trivedi Global, Inc.

Alice Branton, today released research results on the impact of biofield energy treatment on the physicochemical properties of lead.

LAS VEGAS (PRWEB)
August 24, 2019

Alice Branton, today released research results on the impact of biofield energy treatment on the physicochemical properties of lead.

The scientific research shows:

• 
  Over 1970% increase in particle size
• Over 177% increase in crystallite size
• Over 15% alteration in latent heat of fusion

These results suggest that the Trivedi Effect® treatment of lead may have generated a new polymorphic form of the metal which could have more powder flowability and increased thermal stability. Therefore, the treated lead may minimize the potential for lead poisoning. which can lead to an array of diseases such as nephropathy, kidney failure, colic-like abdominal pains, weakness in the fingers, wrists, and ankles, and increased blood pressure. It may cause anemia, miscarriages in pregnant women, and reduced fertility in males.

Lead is a widely used metal for multiple purposes including contraceptives, cosmetics, ornaments, glasses, glazes, enamel, writing materials, currency, construction, and lead-acid batteries.

Alice Branton provided this Biofield Energy Healing Treatment remotely from the United States, while the test samples were in the research laboratory of Dabur Research Foundation, near New Delhi, India. The Biofield Energy Treatment was administered for 3 minutes through the Branton’s unique Energy Transmission process remotely to the test samples under laboratory conditions. In this study, Branton never visited the laboratory in person, nor had any contact with the test item and medium.

About Biofield Energy Treatments

The National Center of Complementary and Integrative Health (NCCIH) has recognized and accepted Biofield Energy Healing Treatments as a complementary and alternative medicine (CAM) health care approach in addition to other therapies, medicines, and practices. CAM therapies have been practiced worldwide with reported clinical benefits in different health disease profiles. Human Biofield Energy has subtle energy that has the capacity to work effectively. This energy can be harnessed and transmitted by the gifted into living and non-living things via the process of a Biofield Energy Healing Treatment or Therapy.

Scientific Publication

Title: Assessment of the Influence of Biofield Energy Treatment on the Physicochemical and Thermal Properties of Lead Using PXRD, PSA, and DSC

Journal: Research and Development in Material Science

Published: October 31, 2018

Authors: Alice Branton, Mahendra Trivedi, Dahryn Trivedi, Gopal Nayak, Snehasis Jana

URL: https://www.alicebranton.com/science/

About Alice Branton

Alice Branton, CEO, Trivedi Global, Inc., recently spoke on the impact of the Trivedi Effect® at the Entrepreneurship Club of the Harvard Business School, Nasdaq, Microsoft, and Coca-Cola. She also appeared on more than 35 network television news shows in the last year including ABC, NBC, FOX, CW and more.

https://www.alicebranton.com

About Guruji Mahendra Trivedi and the Trivedi Effect®

Guruji Mahendra Kumar Trivedi, the founder of the Trivedi Effect®, is on a mission to usher in a new era that integrates science, spirituality, and consciousness to vastly improve the human condition and benefit humanity on a global scale. To date, more than 250,000 people worldwide have benefited from the Trivedi Effect®. His organization, Trivedi Global, Inc., is collaborating with globally renowned product research and development organizations to bring to market proprietary products and therapies in the areas of nutraceuticals, pharmaceuticals, and more.

Dahryn Trivedi is a prodigious spiritual leader, young entrepreneur, and inspiring speaker. Along with Guruji Mahendra Trivedi, she devotes her time to expand and promote awareness about the power and potential of the Trivedi Effect®. She shared her message at NASDAQ and on national media including ABC, NBC, Fox, and CW.

Gopal Nayak is one the youngest enlightened spiritual gurus for the new generation in India. He is a pioneer in Biofield Energy Science. Nayak raises awareness about the potential impact of the Trivedi Effect for the beneficial transformation of all living organisms and non-living materials. Nayak is highly sought after by business leaders, politicians and celebrities throughout India and abroad. Nayak has transformed the lives of thousands of individuals from around the world, especially in the USA, Canada and Europe.

The Trivedi Effect® is an evidence-based phenomenon in which an individual can harness inherently intelligent energy from nature and transmit it to living organisms and non-living materials, anywhere in the world through thought intention, to significantly enhance potency and beneficially alter their characteristics and behaviors through transformation at the atomic, molecular, and cellular levels.

The Trivedi Effect® has been tested, measured, and validated in over 4,000 scientific experiments globally, by world-renowned scientists and research institutes using the rigor of internationally accepted models of scientific research with the most sophisticated technologies available on this planet. Challenging the known frontiers of science, this research has resulted in over 400 publications in major international peer-reviewed scientific journals with over 4,000 citations.

These publications are available in over 4,000 universities internationally including the prestigious Ivy League Universities, as well as, the National Institutes of Health (NIH).

http://www.TrivediEffect.com

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, which may cause actual results in future periods to differ materially from stated results. Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. Statements in this news release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations, and orientations regarding the future. Often, but not always, forward-looking statements can be identified by words such as “may”, “will”, “should”, “would”, “expect”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “seem”, “seek”, “future”, “continue”, “appear”, or variations of such words including negative variations thereof, and phrases that refer to certain actions, events or results that may, could, would, might or will occur or be taken or achieved.

Media Contact

Alice Branton,

Chief Executive Officer

Trivedi Global, Inc.

pr(at)trivedieffect.com

FARMINGTON, Conn. (PRWEB)
August 26, 2019

Shoreline Biome, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, has hired Bill McKenzie as its CEO and Karen Woodward as its VP of Business Development.

These two new hires are expected to help Shoreline Biome meet growing demand for its products and expand the company’s sales worldwide.

Prior to joining Shoreline Biome, Bill McKenzie was a managing partner at Upstart Life Science, a management consulting firm that partners with life science founders to help realize their dream of bringing transformative technologies to the world. McKenzie honed his business skills at Millipore and PerkinElmer where he held both mid-manager and executive level positions. While there, he launched a number of highly successful new businesses in the molecular diagnostics, life science research, and medical device markets and has designed and negotiated numerous partnerships and acquisitions. He has served on a number of life science company boards and is currently a board member at seqWell, a next-generation sequencing company in Beverly, Mass. McKenzie was a board member at WaferGen BioSystems, a genomics company in Freemont, Calif., and was instrumental in its merger with Takara Bio in 2017. He also served on the board at Quad Technologies, a cell separations company, headquartered in Woburn, Mass., and acquired by Bio-Techne in 2018.

Karen Woodward, Ph.D., developed and launched new genomic products in the microarray space at several life sciences companies, including Packard BioChip, PerkinElmer and GeneXP Biosciences. She led strategic business development and partnership efforts at several genomic services laboratories, including Beckman Coulter Genomics, Covance and Generation Health. Woodward was instrumental in multimillion-dollar sales that lead to the 2009 acquisition of Cogenics by Beckman Coulter in 2009, as well as the successful commercialization and launch of Covance Genomics services after the acquisition of Merck’s Rosetta operation in Seattle. Woodward served as VP of Strategic Operations and Account Management at Generation Health (acquired by CVS Caremark) and its spin-out, MetaDiagnostic. Prior to joining Shoreline Biome, Dr. Woodward was the Industry Liaison for Life Sciences at UConn Technology Commercialization Services. She received her Ph.D. in molecular genetics and microbiology from the University of Massachusetts Medical School, Graduate School of Biomedical Sciences, and her B.A. in biology from Clark University.

About Shoreline Biome

Characterizing the human microbiome and analyzing its role in human health and disease are priority goals for researchers around the world. Shoreline Biome accelerates breakthroughs in microbiome research by developing transformative discovery tools that characterize microbiome populations down to the strain level. With Shoreline Biome products, all it takes is three easy steps: lyse, purify, and amplify. Shoreline Biome’s easy-to-use companion analysis software and comprehensive reference database enables straightforward strain-level identification and quantitation of all bacteria in the sample. To learn more, visit shorelinebiome.com.

Share article on social media or email:

This study identifies specific opportunities to expand the current testing guidelines to identify more individuals facing increased cancer risks, who would benefit from more intensive cancer surveillance and/or preventive surgeries.

ALISO VIEJO, Calif. (PRWEB)
August 27, 2019

Ambry Genetics (Ambry), a leading clinical genetics testing company, announced today new opportunities to improve genetic testing guidelines. In the largest cohort study of its kind, Ambry presents novel, detailed evidence on how to improve the guidelines to identify more at-risk patients.

Clinicians use guidelines to inform decisions about which patients should receive genetic testing for hereditary cancer and for those patients which genes should be tested. These guidelines also have implications for how insurance plans cover genetic testing, and for appropriate medical management of patients after testing is complete.

In their recent study published in Genetics in Medicine, researchers from Ambry and Mayo Clinic applied genetic testing criteria from the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology to 165,000 patients who underwent multigene, hereditary cancer panel testing.

Ambry specifically looked at the testing guidelines for BRCA-Related Breast and/or Ovarian Cancer Syndrome (HBOC) and for Lynch Syndrome to better understand how the guidelines for these two common, inherited conditions might be improved to identify more at-risk patients.

The study found that updating the BRCA1 and BRCA2 and Lynch syndrome testing criteria to include more medically actionable, cancer-predisposition genes – and relaxing current criteria, such as age-at-diagnosis constraints – would identify more patients at risk for developing hereditary cancer.

The study found that:

• 1 in 4 (409/1518) patients with pathogenic variants in Lynch syndrome genes would have been missed using current Lynch syndrome testing criteria;
• 1 in 17 (302/5200) patients with pathogenic variants in BRCA1 and BRCA2 would have been missed using current BRCA1 and BRCA2 testing criteria; and
• 3 in 5 (7647/12,847) patients with pathogenic variants in clinically actionable breast and/or ovarian cancer genes would have been missed if tested for BRCA1 and BRCA2 only.

“This study identifies specific opportunities to expand the current testing guidelines to identify more individuals facing increased cancer risks, who would benefit from more intensive cancer surveillance and/or preventive surgeries,” said Holly LaDuca, lead author on the study and senior manager of Clinical Affairs Research at Ambry Genetics.

In addition, this study revealed several new gene-cancer associations that have the potential to impact patient care. For example, pathogenic variants in BARD1 were associated with a 2-fold increased risk for breast cancer. However, there are no recommendations for increased breast cancer surveillance for these variants like there are for other genes associated with similar risk.

“Results from this study refined several gene-cancer associations for which there are no rec-ommendations for increased surveillance and/or preventive surgeries. More studies are need-ed from the genetics community to better understand how these new gene-cancer associations have the potential to impact patient care,” added Ms. LaDuca.

ABOUT AMBRY GENETICS ®

Ambry Genetics, as part of Konica Minolta Precision Medicine, excels at translating scientific research into clinically actionable test results based upon a deep understanding of the human genome and the biology behind genetic disease. Our unparalleled track record of discoveries over 20 years, and growing database that continues to expand in collaboration with academic, corporate and pharmaceutical partners, means we are first to market with innovative products and comprehensive analysis that enable clinicians to confidently inform patient health decisions. We care about what happens to real people, their families, and the people they love, and remain dedicated to providing them and their clinicians with deeper knowledge and fresh insights, so together they can make informed, potentially life-altering healthcare decisions. For more information, please visit ambrygen.com.

Share article on social media or email:

As part of its industry-leading portfolio of emulsifiers, DuPont will introduce DIMODAN® NG 100 at the expo.

NEW CENTURY, Kan. (PRWEB)
August 28, 2019

DuPont Nutrition & Biosciences will offer its baking innovation expertise and wide-ranging DuPont™ Danisco® ingredient solutions to attendees at the International Baking Industry Expo, September 8 to 11, in booth 5015. DuPont uses cutting-edge science to solve today’s baking challenges from optimizing production efficiency to cost and waste reduction and from maintaining freshness throughout shelf life to reformulating for cleaner labels. DuPont offers ingredient technology in applications across the baking industry, including yeast-raised sweet goods, cakes, tortillas, flatbreads, pan breads, buns, rolls, bagels and fillings, glazes and toppings.

As part of its industry-leading portfolio of emulsifiers, DuPont will introduce DIMODAN® NG 100 at the expo. DIMODAN® NG 100 is a non-GMO, next generation emulsifier solution to replace hydrated monoglycerides as a dough conditioner and crumb strengthener in a broad range of applications. Using this new monoglyceride powder instead of hydrated pastes, baking manufacturers achieve similar product yields with a smaller ingredient amount, leading to cost savings and big sustainability gains with this easy-to-use solution.    

Visitors can sample the breadth of DuPont innovations for the baking industry and beyond during the expo. Daypart menus will begin with a Brunch Bar featuring an assortment of on-trend toasts and toppings followed by an afternoon Taco Bar with tortillas and various fillings. Or stop by anytime for a sweet treat! All the food featured offers the perfect chance to discuss market trends, customer challenges, innovation opportunities, and how DuPont’s expertise makes the perfect partnership for success.

Knowledge sharing

On Tuesday, September 10, David ‘Guilley’ Guilfoyle, Group Manager with DuPont, will present an educational session called, Pushing the Boundaries of Freshness Through Hurdle Technology. Attendees will learn about a three-pronged hurdle approach for shelf life extension that uses antioxidants, antimicrobials, and anti-stalling technologies in synergy. Guilfoyle will discuss this in detail, plus a new development called “hyper-extended” shelf life that pushes freshness boundaries even further. The hour-long session begins at 9:45 a.m. CT in room N256.

For more information on all DuPont bakery ingredients and broader food and beverage solutions, go to http://www.food.dupont.com/

About DuPont Nutrition & Biosciences

DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. We are innovative solvers who help our customers turn challenges into high-value business opportunities. For more information: http://www.dupontnutritionandbiosciences.com or http://www.biosciences.dupont.com.

About DuPont

DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food, and worker safety. More information can be found at http://www.dupont.com/.

08/28/19

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

Share article on social media or email: